Dan Yan
Education
Degrees
- PhD from Immunology
Research
Publications
-
Discovery of Novel TYRO3/MERTK Dual Inhibitors.
J Med Chem Volume: 68 Page(s): 8455 - 8470
04/24/2025 Authors: Kong D; Zhao J; Huang D; Stashko MA; Yan D; Ding R; Guduru SKR; Zhou Y; Kania CE; Shelton Earp H -
UNC9426, a Potent and Orally Bioavailable TYRO3-Specific Inhibitor.
J Med Chem Volume: 68 Page(s): 6665 - 6682
03/27/2025 Authors: Kong D; Yang X; Judd S; Yan D; Springborn S; Stashko MA; Kidwell A; Huelse JM; Kireev D; Graham DK -
Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors.
J Med Chem Volume: 67 Page(s): 5866 - 5882
04/11/2024 Authors: Kong D; Tian Q; Chen Z; Zheng H; Stashko MA; Yan D; Earp HS; Frye SV; DeRyckere D; Kireev D -
Corrigendum to "Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J" [DNA Repair9 (2010) 1170-1175].
DNA Repair (Amst) Volume: 134 Page(s): 103631
02/01/2024 Authors: Ng WL; Yan D; Zhang X; Mo Y-Y; Wang Y -
Hope and Challenges: Immunotherapy in EGFR-Mutant NSCLC Patients.
Biomedicines Volume: 11
10/28/2023 Authors: Yan D -
Targeting a positive feedback loop of MERTK and STAT3 during macrophage differentiation may provide anti-tumor immune function
Volume: 83
04/01/2023 Authors: Yan D; Huelse JM; Bhasin SS; Bhasin M; DeRyckere D; Graham DK -
MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancer.
J Clin Invest Volume: 132
08/01/2022 Authors: Yan D; Huelse JM; Kireev D; Tan Z; Chen L; Goyal S; Wang X; Frye SV; Behera M; Schneider F -
Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer.
Cancers (Basel) Volume: 13
11/11/2021 Authors: Yan D; Earp HS; DeRyckere D; Graham DK -
MERTK drives residual tumor growth in EGFR-mutated non-small cell lung cancer cells treated with osimertinib
Volume: 80
08/01/2020 Authors: Yan D; Huelse J; Parker R; Tan Z; Wang X; Frye S; Earp HS; DeRyckere D; Graham DK -
MERTK is a potential therapeutic target in osimertinib-resistant non-small cell lung cancer
Volume: 79
07/01/2019 Authors: Yan D; Huelse J; Parker R; Wang X; Frye SV; Earp HS; DeRyckere D; Graham D